BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 19439915)

  • 21. Prostate cancer genomics: towards a new understanding.
    Witte JS
    Nat Rev Genet; 2009 Feb; 10(2):77-82. PubMed ID: 19104501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic tests could detect high risk of aggressive prostate cancer.
    Hawkes N
    BMJ; 2014 Feb; 348():g1700. PubMed ID: 24563422
    [No Abstract]   [Full Text] [Related]  

  • 23. Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine.
    Aoun F; Rassy EE; Assi T; Kattan J
    Future Oncol; 2016 Oct; 12(20):2359-61. PubMed ID: 27424848
    [No Abstract]   [Full Text] [Related]  

  • 24. The Promise and Perils of Sequencing Individual Prostate Cancer Nuclei.
    Boutros PC
    Eur Urol; 2018 Nov; 74(5):560-561. PubMed ID: 30075977
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on Screening for Urological Malignancies.
    Hoffman A; Half EE
    Rambam Maimonides Med J; 2017 Oct; 8(4):. PubMed ID: 29059045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
    Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
    J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-example.
    Li-Wan-Po A; Farndon P; Craddock C; Griffiths M
    Eur J Clin Pharmacol; 2010 Apr; 66(4):369-74. PubMed ID: 20111860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.
    Donovan MJ; Cordon-Cardo C
    Curr Opin Urol; 2014 May; 24(3):303-10. PubMed ID: 24625431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and basic aspects of familial prostate cancer].
    Suzuki K; Matsui H; Ohtake N
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):159-63. PubMed ID: 23411953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
    Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
    Meyer A; Coinac I; Bogdanova N; Dubrowinskaja N; Turmanov N; Haubold S; Schürmann P; Imkamp F; von Klot C; Merseburger AS; Machtens S; Bremer M; Hillemanns P; Kuczyk MA; Karstens JH; Serth J; Dörk T
    Urol Oncol; 2013 Jan; 31(1):74-81. PubMed ID: 21396839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
    Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Special report: recent developments in prostate cancer genetics and genetic testing.
    Technol Eval Cent Assess Program Exec Summ; 2009 Jan; 23(7):1-3. PubMed ID: 19297804
    [No Abstract]   [Full Text] [Related]  

  • 35. When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.
    Li-Wan-Po A; Farndon P; Cooley C; Lithgow J
    Public Health Genomics; 2010; 13(1):55-62. PubMed ID: 19439915
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.